Pfizer Expands Portfolio with New Acquisition

Pfizer has signed a deal to acquire the consumer health business of Ferrosan, a European healthcare company.

Pfizer Inc. has reached an agreement to purchase Ferrosan's consumer healthcare business, which includes dietary supplements and lifestyle products. Based in Copenhagen, Ferrosan is an innovative and long-established consumer healthcare company with a portfolio of leading brands. The acquisition is expected to close during the second quarter 2011. Financial terms were not disclosed.

"Ferrosan is an excellent strategic fit that strengthens our presence in dietary supplements with a new set of compelling brands and product pipeline," said Paul Sturman, president, Pfizer Consumer Healthcare. "The transaction will mark an important step towards expanding Ferrosan's brands through Pfizer's global footprint. As an immediate result of this acquisition, we will gain greater distribution and scale for Pfizer’s well-known